Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

LeMaitre Vascular Sees Q4 GAAP EPS $0.64-$0.69 vs $0.63 Est; Sees Sales $61.800M-$63.800M vs $64.324M Est

Author: Benzinga Newsdesk | November 06, 2025 04:07pm
LeMaitre Vascular (NASDAQ:LMAT) is looking for Q4 GAAP EPS of $0.64-$0.69 vs $0.63 analyst estimate. sees sales of $61.800 million-$63.800 million vs $64.324 million analyst estimate.

Posted In: LMAT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist